FDA Approved Products
1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
INTERMEZZO
zolpidem tartrate
Peak
Purdue Pharma
SUBLINGUAL · TABLET
2011
NDA8/100
INVEGA SUSTENNA
paliperidone palmitate
Peak
Johnson & Johnson
INTRAMUSCULAR · SUSPENSION, EXTENDED RELEASE
schizophrenia in adultsSchizophrenia
2009
NDA8/100
INVOKAMET
canagliflozin and metformin hydrochloride
Peak
Johnson & Johnson
ORAL · TABLET
established cardiovascular disease ( )nonfatal myocardial infarction+6
2014
NDA8/100
INVOKAMET XR
canagliflozin and metformin hydrochloride
Peak
Johnson & Johnson
ORAL · TABLET, EXTENDED RELEASE
established cardiovascular disease ( )nonfatal myocardial infarction+6
2016
NDA8/100
INVOKANA
canagliflozin
Peak
Johnson & Johnson
ORAL · TABLET
type 2 diabetes mellitustype 1 diabetes mellitus
2013
SMNDA8/100
ISENTRESS
raltegravir
Peak
Merck & Co.
ORAL · TABLET, CHEWABLE
combination with other antiretroviral agents for the treatment of HIV-1 infection in adult patients ()combination with other antiretroviral agents for the treatment of HIV-1 infection in pediatric patients weighing at least 2 kg ()+4
2011
SMNDA8/100
ISENTRESS
raltegravir
Peak
Merck & Co.
ORAL · POWDER
combination with other antiretroviral agents for the treatment of HIV-1 infection in adult patients ()combination with other antiretroviral agents for the treatment of HIV-1 infection in pediatric patients weighing at least 2 kg ()+4
2013
SMNDA8/100
IZBA
travoprost
Peak
Novartis
OPHTHALMIC · SOLUTION/DROPS
2014
NDA8/100
JELMYTO
mitomycin
Peak
NeuroGenesis Bio
PYELOCALYCEAL · POWDER
2020
NDA8/100
JYNARQUE
tolvaptan
Peak
Otsuka
ORAL · TABLET
2018
NDA8/100
KALYDECO
ivacaftor
Peak
Vertex Pharmaceuticals
ORAL · TABLET
2012
NDA8/100
KARBINAL ER
carbinoxamine maleate
Peak
Aytu BioPharma
ORAL · SUSPENSION, EXTENDED RELEASE
2013
NDA8/100
KAZANO
alogliptin and metformin hydrochloride
Peak
Takeda
ORAL · TABLET
type 2 diabetes mellitustype 1 diabetes mellitus
2013
NDA8/100
KOSELUGO
selumetinib
Peak
AstraZeneca
ORAL · CAPSULE
2020
SMNDA8/100
KOVANAZE
oxymetazoline hydrochloride; tetracaine hydrochloride
Peak
NASAL · SPRAY, METERED
2016
NDA8/100
KYLEENA
levonorgestrel
Peak
Bayer
INTRAUTERINE · SYSTEM
pregnancy for up to 5 years
2016
NDA8/100
LUMIFY
brimonidine tartrate
Peak
Bausch + Lomb
OPHTHALMIC · SOLUTION/DROPS
2017
NDA8/100
LUPRON DEPOT
leuprolide acetate
Peak
AbbVie
INJECTION · INJECTABLE
advanced prostate cancerprostate cancer
1995
NDA8/100
LUPRON DEPOT-PED KIT
leuprolide acetate
Peak
AbbVie
INTRAMUSCULAR · POWDER
1993
NDA8/100
MILPROSA
progesterone
Peak
Ferring Pharmaceuticals
VAGINAL · SYSTEM
2020
NDA8/100
MINIVELLE
estradiol
Peak
Noven Pharmaceuticals
TRANSDERMAL · FILM, EXTENDED RELEASE
2012
NDA8/100
MIRAPEX ER
pramipexole dihydrochloride
Peak
Boehringer Ingelheim
ORAL · TABLET, EXTENDED RELEASE
2010
NDA8/100
MIRENA
levonorgestrel
Peak
Bayer
INTRAUTERINE · SYSTEM
pregnancy for up to 8 yearsheavy menstrual bleeding for up to 5 years in women+2
2000
NDA8/100
MITOSOL
mitomycin
Peak
Glaukos
TOPICAL · FOR SOLUTION
2012
NDA8/100